April 20 (Bloomberg) -- Ayrton Drug Manufacturing Ltd., a manufacturer of pharmaceutical products in Ghana, rose to the highest since Feb. 3 on speculation a “strategic investor” acquired a stake in the company.
The stock gained 1 pesewa, or 6.3 percent, to close at 17 pesewas as of 2:40 p.m. in the capita, Accra.
“A strategic investor was taking a position in the company,” Hilary Lomotey, a trader with Renaissance Capital said in a telephone interview from Accra, declining to give details. “The person has an interest in a pharmaceuticals company and Ayrton Drug is the biggest in terms of market capitalization on Ghana’s market.”
To contact the editor responsible for this story: Antony Sguazzin at firstname.lastname@example.org.